Does Rallies show 13F holders for PBYI?

Yes. Rallies tracks hedge fund and 13F ownership data for PBYI, including fund names, share counts, latest tracked quarter, and position changes when available.

Is PBYI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PBYI. It does not provide personalized investment advice.

PBYI (PUMA BIOTECHNOLOGY INC) Stock Analysis - Hedge Fund Holdings

PUMA BIOTECHNOLOGY INC (PBYI) is a publicly traded Healthcare sector company. As of May 21, 2026, PBYI trades at $7.00 with a market cap of $346.63M and a P/E ratio of 13.95. PBYI moved +2.50% today. Year to date, PBYI is +17.68%; over the trailing twelve months it is +92.56%. Its 52-week range spans $2.32 to $7.90. Analyst consensus is neutral with an average price target of $5.00. Rallies surfaces PBYI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns PBYI stock?

Hedge funds tracked by Rallies that own PBYI include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for PUMA BIOTECHNOLOGY INC.

PBYI Key Metrics

Key financial metrics for PBYI
Metric	Value
Price	$7.00
Market Cap	$346.63M
P/E Ratio	13.95
EPS	$0.50
Dividend Yield	0.00%
52-Week High	$7.90
52-Week Low	$2.32
Volume	33
Avg Volume	0
Revenue (TTM)	$227.18M
Net Income	$24.38M
Gross Margin	74.46%

Top Hedge Funds Holding PBYI

Panagora Asset holds 194.89K shares of PBYI, changed +0.00% as of Mar 31, 2026.

Latest PBYI News

Puma Biotechnology Q4 Revenue Hits $75.5M on $59.9M NERLYNX Sales — Feb 27, 2026
Puma Biotech Beats Q4 Estimates: EPS 20.8% Above, Revenues +11% — Feb 27, 2026

Recent PBYI Insider Trades

AUERBACH ALAN H sold 18.01K (~$105.89K) on Jan 7, 2026.
HUNT DOUGLAS M sold 5.01K (~$29.48K) on Jan 7, 2026.
NOUGUES MAXIMO F sold 6.41K (~$37.65K) on Jan 7, 2026.

PBYI Analyst Consensus

1 analysts cover PBYI: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $5.00.

Common questions about PBYI

Who owns PBYI stock?: Hedge funds tracked by Rallies that own PBYI include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for PUMA BIOTECHNOLOGY INC.
Does Rallies show 13F holders for PBYI?: Yes. Rallies tracks hedge fund and 13F ownership data for PBYI, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PBYI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PBYI. It does not provide personalized investment advice.